Elma S. Hawkins

Statistics

Publications

Citations

459

H-Index

Active since

1988

Affiliations

ImmunoCellular Therapeutics (United States)(Current)

Harvard University

Cedars-Sinai Medical Center

Elma S. Hawkins is an author at ImmunoCellular Therapeutics (United States) specializing in cancer immunotherapy, immunotherapy for brain tumors, and medicine.

Publications per year

1988–2014

Publications

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

Surasak Phuphanich, Christopher J. Wheeler, Jeremy Rudnick et al. · Cancer Immunology Immunotherapy · 2012 · 383 citations · Full text

Life Sciences, Immunology, Oncology +17

A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.

Patrick Y. Wen, David A. Reardon, Surasak Phuphanich et al. · Journal of Clinical Oncology · 2014 · 40 citations

Medicine, Immunology, Oncology +17

6- and 8-Hydroxy-3,4-dihydro-3-(dipropylamino)-2H-1-benzopyrans. Dopamine agonists with autoreceptor selectivity

Lawrence D. Wise, Horace A. DeWald, Elma S. Hawkins et al. · Journal of Medicinal Chemistry · 1988 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Japanese-originated pharmaceutical products in the United States from 1960 to 1989: An assessment of innovation

Elma S. Hawkins, Michael R. Reich · Clinical Pharmacology & Therapeutics · 1992 · 11 citations

Management, Innovation Management, Pharmaceutical Policy +12

1–4 of 4